The recurrent mutation of DDX3X was also detected in Natural killer/T-cell lymphoma (NKTCL) patients and resulted in the aberrant cell cycle progression and NF-κB/MAPK signaling activation [29]. The gene discussed is NFKB1; the disease is extranodal nasal NK/T cell lymphoma.